Home › Funds › FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC › JNJ

FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC position in JNJ

JOHNSON & JOHNSON · Health Care

FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC reported holding 99,685 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$26.4M, representing 2.23% of its reported portfolio and ranking #10 among its reported holdings. FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)99.69K sh
Reported value held$26.39M
Portfolio Weight2.23%
First reportedQ3 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC's JNJ position evolved

FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC first disclosed a stake in JNJ in Q3 2023 at 108,140 shares (US$16.8M). The position peaked in Q3 2026 at 99,685 shares, worth US$26.4M. Across 13 filings, FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 99,685 shares valued at US$26.4M — a reduction of -3,514 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 108.14K $16.84M New
Q4 2023 106.73K $16.73M Reduce
Q1 2024 106.85K $16.90M Hold
Q2 2024 107.19K $15.67M Hold
Q3 2024 105.79K $17.14M Reduce
Q4 2024 103.66K $14.99M Reduce
Q1 2025 102.34K $16.97M Reduce
Q2 2025 101.20K $15.46M Reduce
Q3 2025 100.55K $18.64M Reduce
Q4 2025 100.17K $20.73M Hold
Q1 2026 104.04K $25.43M Add
Q2 2026 103.20K $26.21M Reduce
Q3 2026 99.69K $26.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC held JNJ?

FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC's current position in JNJ?

As of Q3 2026, FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC holds 99.69K shares of JNJ (JOHNSON & JOHNSON), valued at $26.39M, representing 2.23% of its reported portfolio and ranking #10.

Has FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC reduced its position in JNJ. The position peaked in Q3 2026 at 99.69K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.